Ovid Therapeutics Inc. Cash
Ovid Therapeutics Inc. (OVID) had Cash of $4.32 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-13
- 2026-06-30: Cash $4.32M.
- 2026-03-31: Cash $12.88M.
- 2025-12-31: Cash $516.00K.
- 2025-09-30: Cash $127.00K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $4.32M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $12.88M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $516.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $127.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.68M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.21M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $522.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $1.78M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.04M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.70M 10-K · filed 2025-03-11 | $2.70M 10-K · filed 2024-03-08 |
| 2023-09-30 | $809.18K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $868.60K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $2.35M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $2.85M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |